![Recently, the man referred to as the "Dusseldorf patient" became at least the third person to have been “cured of HIV” after a bone marrow transplant carrying a specific HIV-resistant mutation Recently, the man referred to as the "Dusseldorf patient" became at least the third person to have been “cured of HIV” after a bone marrow transplant carrying a specific HIV-resistant mutation](https://vajiramandravi.s3.us-east-1.amazonaws.com/media/2023/2/24/13/8/52/CCR5_Delta_32_mutation.png)
Recently, the man referred to as the "Dusseldorf patient" became at least the third person to have been “cured of HIV” after a bone marrow transplant carrying a specific HIV-resistant mutation
![Frontiers | CCR5 as a Coreceptor for Human Immunodeficiency Virus and Simian Immunodeficiency Viruses: A Prototypic Love-Hate Affair Frontiers | CCR5 as a Coreceptor for Human Immunodeficiency Virus and Simian Immunodeficiency Viruses: A Prototypic Love-Hate Affair](https://www.frontiersin.org/files/Articles/835994/fimmu-13-835994-HTML-r1/image_m/fimmu-13-835994-g001.jpg)
Frontiers | CCR5 as a Coreceptor for Human Immunodeficiency Virus and Simian Immunodeficiency Viruses: A Prototypic Love-Hate Affair
![CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo: Molecular Therapy CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo: Molecular Therapy](https://www.cell.com/cms/attachment/2119340444/2092430962/fx1.jpg)
CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo: Molecular Therapy
![Designer Nucleases: Gene-Editing Therapies using CCR5 as an Emerging Target in HIV | Bentham Science Designer Nucleases: Gene-Editing Therapies using CCR5 as an Emerging Target in HIV | Bentham Science](http://www.eurekaselect.com/images/graphical-abstract/chr/17/5/001.jpg)
Designer Nucleases: Gene-Editing Therapies using CCR5 as an Emerging Target in HIV | Bentham Science
![The Strategies and Challenges of CCR5 Gene Editing in Hematopoietic Stem and Progenitor Cells for the Treatment of HIV | SpringerLink The Strategies and Challenges of CCR5 Gene Editing in Hematopoietic Stem and Progenitor Cells for the Treatment of HIV | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12015-021-10145-7/MediaObjects/12015_2021_10145_Figa_HTML.png)